Preclinical Evaluation of <sup>68</sup>Ga-labeled RGD Peptide for Detection of Malignant Angiogenesis

Preclinical Evaluation of <sup>68</sup>Ga-labeled RGD Peptide for Detection of Malignant Angiogenesis

Introduction. The early detection of tumor growth remains one of the most important tasks of diagnostic nuclear medicine. The vascular growth being created malignant neoplasms is a good target for the purpose. The molecular participants in the process are gallium-68 labeled vector to the delivery of...

Full description

Bibliographic Details
Main Authors: O. E. Klementyeva, A. B. Bruskin, A. S. Lunev, M. G. Rakhimov, K. A. Luneva, G E. Codina
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2020-08-01
Series:Разработка и регистрация лекарственных средств
Subjects:
pet
diagnostics
tumor
angiogenesis
gallium-68
«vascular, <sup>68</sup>ga»
xenograft
rgd
Online Access:https://www.pharmjournal.ru/jour/article/view/833

Similar Items

Similar Items